Greater access to life-changing medicine for Australians with ADHD

Australian adults living with Attention Deficit Hyperactivity Disorder (ADHD) will soon have more affordable access to a life-changing treatment option, thanks to its expanded listing on the Pharmaceutical Benefits Scheme (PBS).   Federal Member for Page Kevin Hogan said from today the Government is expanding the listing of Vyvanse® (lisdexamfetamine) to include patients who are…

Big things to come in 2021

Australia is leading the world in fighting COVID-19 and our economy is one of the strongest globally. Speaking to many of our local businesses, they are starting to bounce back.   A recent Deloitte Access Economics report says, “you’d rather be here (Australia) than almost anywhere else” in the world. It continues by saying our…

New Year brings New PBS listings

The first day of the new year brought with it new hope for Australians fighting one of the most common blood cancers, thanks to a critical new medicine listed on the Pharmaceutical Benefits Scheme (PBS).On 1st January 2021, Darzalex® (daratumumab) was listed for the first time in combination with bortezomib and dexamethasone, as a second-line…